Fundraising FoxIndieBio — 2026 Investments
4 investments dated 2026 · listed companies and verified rows first · show all
Antarka develops a skin-permeable enzyme derived from Antarctic organisms that repairs UV-induced DNA damage, offered as a high-purity active ingredient for cosmetic brands to formulate into anti-aging creams, sunscreens, and repair serums.
BiotechConsumerDeep Tech
Betania Martínez(Founder)in
Co-investorsAIR CapitalGRIDXGS FuturesVox CapitalZentynel Frontier Investments
Fermeate develops a hardware module that connects to existing bioreactors and uses precisely timed light pulses to trigger genetic switches in production microorganisms, controlling yield, strain stability, and feedstock flexibility.
BiotechFoodTechHardwareSan Francisco, US
Ke Xu, PhD(Founder)inSaurabh Malani(Executive Officer, Director)Ke Xu(Executive Officer, Director)
BoardPo Bronson(Director)in
Co-investorsHeuristic Capital PartnersNewfund CapitalSOSV
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
EndarisXtelligence
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.